Trial Profile
Use of Tocofersolan (Vedrop) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Tocofersolan (Primary)
- Indications Vitamin E deficiency
- Focus Therapeutic Use
- 11 May 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 13 Dec 2019 Planned initiation date changed from 1 Sep 2019 to 1 Dec 2020.
- 01 Jul 2019 Planned initiation date changed from 1 Jul 2019 to 1 Sep 2019.